Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Exceptional Responders to Hypomethylating Agents in Myeloid Neoplasms: The Miami Experience

Venkata Thammineni, MD, Terrence J Bradley, MD, Felipe Novoa, NP, Deukwoo Kwon, Justin M. Watts, MD

Blood (2019) 134 (Supplement_1): 5107.

https://doi.org/10.1182/blood-2019-131006

Published: 2019

Journal Articles

Phase 1 Dose-Finding Study Investigating CA-4948, an IRAK4 Kinase Inhibitor, in Patients with R/R NHL: Report of Initial Efficacy and Updated Safety Information

Anas Younes, MD, Grzegorz Nowakowski, MD, Allison C. Rosenthal, DO, Lori A. Leslie, MD, Han W. Tun, MD, Matthew A. Lunning, DO, FACP, Iris Isufi, MD, Robert Martell, MD PhD, Krish Patel, MD

Blood (2019) 134 (Supplement_1): 5327.

https://doi.org/10.1182/blood-2019-131851

Published: 2019

Journal Articles

Acute Promyelocytic Leukemia (APL) in Very Elderly Patients: Real-Life behind Protocols

Serena Rosati, MD, Massimo Breccia, MD, Carmelo Gurnari, MD, Ida Carmosino, Emilia Scalzulli, MD, Enrico Montefusco, Salvatore Perrone, MD, Ombretta Annibali, Vincenza Martini, MD, Giulio Trapè, Malgorzata Monika Trawinska, MD, Clara Minotti, MD, Giuseppe Cimino, MD, Agostino Tafuri, MD, Giuseppe Avvisati, MD, Maria Teresa Voso, MD, Robin Foà, MD, Roberto Latagliata

Blood (2019) 134 (Supplement_1): 3845.

https://doi.org/10.1182/blood-2019-129216

Published: 2019

Journal Articles

Single Institution Experience of Gastrointestinal Involvement of Diffuse Large B- Cell Lymphoma: Presentation, Outcomes and Patterns of Treatment Failure

Puja C. Arora, MD, Victor M. Orellana-Noia, MD, Abeer Alfaraj, MBBS, Wenzinger Christopher, MD, Sandra Monson, PhD, Gina Petroni, PhD, Craig A. Portell, MD, Michael E. Williams, MD

Blood (2018) 132 (Supplement 1): 2982.

https://doi.org/10.1182/blood-2018-99-117651

Published: 2018

Journal Articles

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

David K. Buchbinder, MD MSHS, Ruta Brazauskas, PhD, Khalid Bo-Subait, Karen K. Ballen, MD, Theresa E. Hahn, PhD, Tami D John, MD, Susan K Parsons, MD MRP, Shahrukh K. Hashmi, MD MPH, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 2260.

https://doi.org/10.1182/blood-2018-99-116531

Published: 2018

Journal Articles

Hemophagocytic Lymphohistiocytosis: A Retrospective Single-Center Experience

Jessica M Stempel, MD, Priyanka Mittar, DO, Vivian Arguello, MD, Andres L Mora Carpio, MD, Mitali Sen, MD, Mark S Morginstin, DO

Blood (2017) 130 (Supplement 1): 4810.

https://doi.org/10.1182/blood.V130.Suppl_1.4810.4810

Published: 2017

Journal Articles

Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults

Brooke Allemang, MSW, RSW, Kate Allan, MSW, Colleen Johnson, BScN, MN/NP, Melina Cheong, BScN, MN/NP, Patrina Cheung, BSc, Isaac Odame, MBChB, FRCPath, FRCPC, Richard Ward, MSc, MRCP, FRCPath, Suzan Williams, MD MSc, FRCPC, Kevin H.M. Kuo, MD MSc, FRCPC

Blood (2016) 128 (22): 317.

https://doi.org/10.1182/blood.V128.22.317.317

Published: 2016

Journal Articles

Suspicious, Non-MDS-Diagnostic Bone Marrows Have a High Incidence of Clonal Hematopoiesis (CHIP), with MDS-like Clone Size but Restricted Mutation Burden

Brooke Snetsinger, MSc, Emily Heath, BSc, Michael J. Rauh, MD PhD

Blood (2015) 126 (23): 1668.

https://doi.org/10.1182/blood.V126.23.1668.1668

Published: 2015

Journal Articles

Subtypes and Treatment Outcomes of Adolescent and Adult Non-Hodgkins Lymphoma in a Resource Poor Setting

Yvonne Akotoa Dei-Adomakoh, MBBS, Eugenia Quartey, MBChB, Catherine Idara Segbefia, MBChB, Elsie Amedonu, BSc, Afua Abrahams, MBChB, Joseph Acquaye, MBBS

Blood (2015) 126 (23): 1482.

https://doi.org/10.1182/blood.V126.23.1482.1482

Published: 2015

Journal Articles

Diagnosis and Treatment of Myeloproliferative Neoplasms in Germany: First Results from the SAL-MPN Registry

Andrea Kaifie, MD, Susanne Isfort, MD, Dominik Wolf, MD, Mathias Hanel, MD, Christoph Maintz, MD, Norbert Gattermann, MD PhD, Uwe Platzbecker, MD, Eray Goekkurt, MD, Ina Boeters, MD, Richard Hansen, MD, Fabian Lang, MD, Joachim R. Goethert, Karla Bennemann, MD, Christoph Rollig, MD MSC, Hubert Serve, MD, Wolfgang E Berdel, MD, Gerhard Ehninger, MD, Tim H Bruemmendorf, MD, Steffen Koschmieder, MD

Blood (2014) 124 (21): 5561.

https://doi.org/10.1182/blood.V124.21.5561.5561

Published: 2014

Journal Articles

Using Natural Language Processing to Determine Chemotherapeutic Regimens Administered within 30 Days Prior to Death in Acute Myelogenous Leukemia Patients

Hanahlyn M Park, BSN, MN(c), Vicky Sandhu, MD MPH, Paul Fearn, MBA, PhDc), Kathleen Shannon Dorcy, RN, MN, PhD, Elihu H. Estey, MD, Emily Silgard, MS

Blood (2014) 124 (21): 1267.

https://doi.org/10.1182/blood.V124.21.1267.1267

Published: 2014

Journal Articles

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Rena Buckstein, MD, Richard A. Wells, MD DPhil, Nancy Zhu, MD, Thomas J. Nevill, MD, Heather A Leitch, MD PhD, Karen W.L. Yee, MD, Brian Leber, MD, Mitchell Sabloff, MDM, Rajat Kumar, MD, Michelle Geddes, MD, April Shamy, MDM, Max Levitt, Martha Lenis, Alex Mamedov, Liying Zhang, PhD, Shabbir MH Alibhai, MD

Blood (2014) 124 (21): 165.

https://doi.org/10.1182/blood.V124.21.165.165

Published: 2014

Journal Articles

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Patrick T. McGann, MD, Margarida Muhongo, Elizabeth McGann, Vysolela de Oliveira, Brigida Santos, MD, Russell E. Ware, MD, PhD

Blood (2013) 122 (21): 2934.

https://doi.org/10.1182/blood.V122.21.2934.2934

Published: 2013

Journal Articles

Long Term Outcome of Patients Enrolled Into STOP and STOP II Trials: A Single Center Experience

Gloria Sayer, Latanya Bowman, RN, Betsy Clair, Austin Cail, Beverly Blanchard, Kavita Natrajan, MBBS, Virgil McKie, MD, Robert J. Adams, MD, MS, Abdullah Kutlar, MD

Blood (2012) 120 (21): 3219.

https://doi.org/10.1182/blood.V120.21.3219.3219

Published: 2012

Journal Articles

Long-Term Outcomes of Renal Function in Patients with TTP Associated with Severe ADAMTS13 Deficiency

Jessica A Reese, MS, Cassandra C Deford, BA, Zayd Al-Nouri, MD, MPH, Deirdra Terrell, PhD, Sara K. Vesely, PhD, MPH, Johanna A. Kremer Hovinga Strebel, MD, Bernhard Lammle, James N. George, MD

Blood (2011) 118 (21): 2215.

https://doi.org/10.1182/blood.V118.21.2215.2215

Published: 2011

Journal Articles

Treatment Related Mortality of AML Pediatric Patients in a Single Center in Saudi Arabia

Wasil Jastaniah, MBBS, FRCPC, Mohammed Burhan Abrar, PhD, Taha Khattab, MD

Blood (2011) 118 (21): 4291.

https://doi.org/10.1182/blood.V118.21.4291.4291

Published: 2011

Journal Articles

Reinduction Chemotherapy for AML: Comparison Between CECA, High Dose Cytarabine and CLAG-M

Christina Escobar, B.S., Sukanthini Subbiah, MD, Maxim Norkin, MD, PhD, Helen Leather, BPharm, Ashley Richards, Pharm.D., Randy A. Brown, MD, W. Stratford May, John R. Wingard, MD, Jack W Hsu, MD, Christopher R Cogle, M.D.

Blood (2011) 118 (21): 4301.

https://doi.org/10.1182/blood.V118.21.4301.4301

Published: 2011

Journal Articles

HLH (Hemophagocytic Lymphohistiocytosis) At a Tertiary Care Hospital, B J Wadia Hospital for Children,In Mumbai, India

Mukesh Manharlal Desai, MBBS, MD, Harvinder Iqbal Palaha, MBBS, MD, Snehal Desai, MBBS, MD, Manisha Madkaikar, MBBS, MD, Bharat Agarwal, MBBS, MD, Nitin Shah, MBBS, MD, Archana Swami, MD, MBBS, MRCP, Kanjaksha Ghosh

Blood (2011) 118 (21): 4936.

https://doi.org/10.1182/blood.V118.21.4936.4936

Published: 2011

Journal Articles

Different Definitions of Progression-Free Survival (PFS) and Event-Free Survival (EFS) May Result In Perceived but Not Real Differences In Long-Term Outcome When Comparing Trials In Chronic Myeloid Leukemia (CML)

Hagop Kantarjian, MD, Susan O'Brien, MD, Elias Jabbour, MD, Jianqin Shan, PhD, Farhad Ravandi, MD, Tapan Kadia, MD, Jorge E. Cortes, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD

Blood (2010) 116 (21): 672.

https://doi.org/10.1182/blood.V116.21.672.672

Published: 2010

Journal Articles

Low Mortality In Sickle Cell Patient Cohort with Elevated Tricuspid Regurgitant Jet Flow Velocity

Eduard J. Beers van, MD, PhD, Charlotte F.J. Tuijn, R.N., M.S., Erfan Nur, M.D., Anita W. Rijneveld, M.D., PhD, M. R. Mac Gillavry, M.D., PhD, Ashley Duits, PhD, Dees P Brandjes, M.D., PhD, John-John Schnog, MD, PhD, Bart J. Biemond, MD, PhD

Blood (2010) 116 (21): 1641.

https://doi.org/10.1182/blood.V116.21.1641.1641

Published: 2010

NARROW

Exceptional Responders to Hypomethylating Agents in Myeloid Neoplasms: The Miami Experience

Phase 1 Dose-Finding Study Investigating CA-4948, an IRAK4 Kinase Inhibitor, in Patients with R/R NHL: Report of Initial Efficacy and Updated Safety Information

Acute Promyelocytic Leukemia (APL) in Very Elderly Patients: Real-Life behind Protocols

Single Institution Experience of Gastrointestinal Involvement of Diffuse Large B- Cell Lymphoma: Presentation, Outcomes and Patterns of Treatment Failure

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Hemophagocytic Lymphohistiocytosis: A Retrospective Single-Center Experience

Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults

Suspicious, Non-MDS-Diagnostic Bone Marrows Have a High Incidence of Clonal Hematopoiesis (CHIP), with MDS-like Clone Size but Restricted Mutation Burden

Subtypes and Treatment Outcomes of Adolescent and Adult Non-Hodgkins Lymphoma in a Resource Poor Setting

Diagnosis and Treatment of Myeloproliferative Neoplasms in Germany: First Results from the SAL-MPN Registry

Using Natural Language Processing to Determine Chemotherapeutic Regimens Administered within 30 Days Prior to Death in Acute Myelogenous Leukemia Patients

Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry

Successful Outcomes Of An Infant Sickle Cell Clinic In Luanda, Angola

Long Term Outcome of Patients Enrolled Into STOP and STOP II Trials: A Single Center Experience

Long-Term Outcomes of Renal Function in Patients with TTP Associated with Severe ADAMTS13 Deficiency

Treatment Related Mortality of AML Pediatric Patients in a Single Center in Saudi Arabia

Reinduction Chemotherapy for AML: Comparison Between CECA, High Dose Cytarabine and CLAG-M

HLH (Hemophagocytic Lymphohistiocytosis) At a Tertiary Care Hospital, B J Wadia Hospital for Children,In Mumbai, India

Different Definitions of Progression-Free Survival (PFS) and Event-Free Survival (EFS) May Result In Perceived but Not Real Differences In Long-Term Outcome When Comparing Trials In Chronic Myeloid Leukemia (CML)

Low Mortality In Sickle Cell Patient Cohort with Elevated Tricuspid Regurgitant Jet Flow Velocity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only